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 Abstract 
  Background/Aims:   Colony-stimulating factors (CSFs) are well-known hematopoietic growth 
factors. Although recent studies revealed that CSFs are involved in many inflammatory condi-
tions, the local production of CSFs and its regulation in the kidney is not well elucidated. There-
fore, using cultured human proximal tubular epithelial cells (PTEC), we examined the effect of 
thrombin on CSFs production, since thrombin has been suggested to play an important role in 
tubulointerstitial injury.   Methods:   PTEC were incubated with thrombin (0.5–5.0 U/ml) and the 
effects on the production of macrophage CSF (M-CSF), granulocyte-macrophage CSF (GM-CSF) 
and granulocyte CSF (G-CSF) were measured in the cell supernatant by enzyme-linked immu-
nosorbent assay, and the expressions of mRNA were analyzed by quantitative real-time reverse 
transcription polymerase chain reaction. Using argatroban, a direct thrombin inhibitor, we also 
examined the specific effect of thrombin.   Results:   Thrombin 5.0 U/ml significantly stimulated 
the production of M-CSF (p   !   0.01) and G-CSF (p   !   0.01), and 1.0 and 5.0 U/ml thrombin signifi-
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cantly stimulated GM-CSF (p   !   0.02 and p   !   0.01) in a dose-dependent manner. Thrombin 5.0 
U/ml increased CSFs (M-CSF, p   !   0.005; GM-CSF, p   !   0.0005; G-CSF, p   !   0.005) in a time-depen-
dent manner. Thrombin also significantly enhanced the mRNA expressions of M-CSF (p   !   0.01), 
GM-CSF (p   !   0.05) and G-CSF (p   !   0.01). These effects of thrombin were significantly reduced 
by the addition of argatroban (M-CSF, p   !   0.01; GM-CSF, p   !   0.01; G-CSF, p   !   0.05).   Conclusion:  
We demonstrated that thrombin significantly increased the production of CSFs by PTEC. These 
data suggest that the local production of CSFs in the tubulointerstitium may affect tubuloint-
erstitial lesions in kidney injury.    Copyright © 2012 S. Karger AG, Basel 
 Introduction 
  Macrophage colony-stimulating factor (M-CSF), granulocyte-macrophage CSF (GM-
CSF) and granulocyte CSF (G-CSF) are well-known hematopoietic growth factors. However, 
recent studies revealed that CSFs act not only on hematopoietic cells but on various cell types 
and are involved in many inflammatory conditions. CSFs are suggested to exacerbate auto-
immune-mediated inflammatory diseases including systemic lupus erythematosus and 
rheumatoid arthritis. Currently, the efficacy of an antagonist of GM-CSF is under clinical 
trials as a new therapeutic option for rheumatoid arthritis   [1]  .
    Some evidence suggested harmful effects of CSFs in the kidney. In MRL-Fas lpr mice, 
urine M-CSF levels correlated with lupus activity, and lupus nephritis was reduced by sys-
temic depletion of M-CSF   [2]  . Furthermore, in an experimental antiglomerular membrane 
glomerulonephritis model, both glomerular lesions and tubulointerstitial lesions were at-
tenuated in GM-CSF knockout mice compared with the wild type. In this model, the authors 
suggested the critical role of locally produced GM-CSF   [3]  . However, there is some evidence 
showing that G-CSF could be protective. G-CSF accelerated the recovery from acute tubular 
injury from cisplatin-induced acute kidney injury by accelerating regeneration and by pre-
venting apoptosis of renal tubular cells   [4]  . However, the knowledge about the local produc-
tion of CSFs and its regulation in the kidney is very limited.
    Tubulointerstitial damage plays a pivotal role in progressive renal injury. Fibrin deposi-
tion is commonly observed in the peritubular capillaries and along the tubular basement 
membrane in tubulointerstitial damage in various renal diseases, including obstructive ne-
phropathy, experimental lupus nephritis, ischemic tubular necrosis and chronic allograft 
nephropathy  [5–11] . Thrombin which is generated in the process of fibrin formation has been 
detected in the urine of patients with glomerulonephritis   [12]  . Recent evidence suggests that 
thrombin also induces various inflammatory responses in addition to its role in blood co-
agulation   [13]  . Thus, thrombin is suggested as one of the pathogenic mediators in tubuloin-
terstitial injury.
    In this study, we hypothesized that local expression of CSFs in the kidney may be in-
creased in tubulointerstitial injury, and using cultured human proximal tubular epithelial 
cells (PTEC), we examined CSFs production stimulated by thrombin.
  M e t h o d s  
 Cell  Culture 
  Primary human PTEC were purchased from BioWhittaker (Walkersville, Md., USA). 
The cells were cultured with Renal Epithelial Cell Growth Medium BulletKit (REBM) sup-
plemented with 5     g/ml insulin, 10     g/ml transferrin, 0.5     g/ml hydrocortisone, 6.5 ng/ml 3
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trio-iodothyronine, 0.5     g/ml epinephrine, 10 ng/ml epidermal growth factor and 0.5% 
heat-inactivated fetal bovine serum (all from BioWhittaker) at 37    °    C in 5% CO  2  . PTEC be-
tween passages 4 and 5 were used for the experiments.
    Assay of M-CSF, GM-CSF and G-CSF 
  M-CSF, GM-CSF and G-CSF were quantified by an enzyme-linked immunosorbent as-
say (ELISA) using the Immunoassay Kit (R&D, O’Fallon, Mo., USA). This assay is a sandwich 
ELISA using an antibody original for human M-CSF, GM-CSF and G-CSF. No significant 
cross-reactivity with other cytokines was observed.
    PTEC were cultured in 12-well plates (Becton Dickinson, Franklin Lakes, N.J., USA). 
Confluent cells were washed twice with Hanks’ balanced salt solution (Gibco Laboratories, 
Grand Island, N.Y., USA) and incubated with Dulbecco’s modified Eagle’s minimum essen-
tial medium (DMEM, Gibco Laboratories) containing 0.2% bovine serum albumin (BSA; 
Sigma, St. Louis, Mo., USA) for 24, 48, or 72 h. Then the levels of M-CSF, GM-CSF and G-
CSF were measured in the culture supernatant. After removing the culture supernatant, the 
cells in each well were dissolved in 1   N   NaOH and the protein content was measured by the 
method of Lowry et al.   [14]   using BSA as the standard. Then the levels of M-CSF, GM-CSF 
and G-CSF were expressed as picograms per microgram of PTEC protein.
    Quantitative Reverse-Transcription Polymerase Chain Reaction 
  Confluent PTEC cultured in 6- well plates (Becton Dickinson ) were incubated with 
DMEM containing 0.2% BSA with or without thrombin (5.0 U/ml) for 6 h. The expression 
of M-CSF, GM-CSF and G-CSF mRNA in PTEC was quantified by real-time reverse tran-
scription polymerase chain reaction (RT-PCR). Total RNA was extracted from the cells using 
an RNeasy Protect Mini Kit (QIAGEN, Valencia, Calif., USA). The RNA was transcribed into 
first-strand cDNA with an Omniscript RT kit (QIAGEN). Quantitative RT-PCR was per-
formed using an ABI PRISM 7700 Sequence Detector (PE Applied Biosystems, Foster City, 
Calif., USA). Specific primers for human M-CSF (Hs99999083_m1), GM-CSF (Hs00929873_
m1), G-CSF (Hs99999084_m1) and GAPDH (Hs99999905_m1) were obtained from Applied 
Biosystems. The relative expression levels of M-CSF, GM-CSF and G-CSF mRNA in the 
samples were normalized by GAPDH mRNA. 
    Stimulation of M-CSF, GM-CSF and G-CSF Production with Thrombin 
  Confluent PTEC cultured in 12-well plates (Becton Dickinson) were incubated with 
DMEM containing 0.2% BSA containing 0.5–5.0 U/ml     -thrombin (Sigma) for 72 h. Then 
we measured M-CSF, GM-CSF and G-CSF in the supernatant of PTEC to determine the dose 
effect of thrombin. The time effect of thrombin was also examined by incubating PTEC with 
or without 5.0 U/ml thrombin for 24, 48, and 72 h. In addition, we also examined the inhib-
itory effect of argatroban, a synthetic thrombin inhibitor (Mitsubishi Kasei Corporation, 
Tokyo, Japan). PTEC were incubated for 72 h with 5.0 U/ml thrombin alone, 5.0 U/ml throm-
bin plus argatroban (1     mol), or argatroban (1     mol) alone. Then M-CSF, GM-CSF and G-
CSF were measured in the culture supernatant.
    We estimated the cytotoxicity of thrombin and argatroban to the PTEC used in this ex-
periment. PTEC were incubated in 24-well plates (Becton Dickinson) for 24 h, and the lactate 
dehydrogenase (LDH) levels in the cell supernatant were measured. After removing the cell 
supernatant, PTEC were lysed by melittin (50     g/ml, Sigma) and the LDH levels in the cell 
lysates were also measured. LDH was quantified by a colorimeter using an LDH assay kit 
(Sanassay LDH; Sankou-Junyaku, Inc., Tokyo, Japan). There was no significant release of 
LDH from PTEC and we thought the concentrations of thrombin and argatroban which we 
used in this experiment showed no cytotoxicity.4
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  Statistical  Analysis 
  All data are expressed as mean   8   1 standard deviation. Results were compared using 
the one-way factorial ANOVA and multiple comparison tests for the dose effect of thrombin 
and the effect of argatroban, the two-way repeated-measures ANOVA for the time effect of 
thrombin, and the unpaired t test for the quantification of mRNA. p   !   0.05 was considered 
significant.
  R e s u l t s  
  Thrombin Stimulates the Production of M-CSF, GM-CSF and G-CSF in PTEC 
  PTEC were incubated with or without thrombin for 72 h. The mean level of M-CSF 
from three wells was 11.20   8   1.90 pg/    g protein at thrombin 0 U/ml, 13.70   8   3.98 pg/   g 
protein at thrombin 0.5 U/ml, 27.33   8   4.03 pg/    g protein at thrombin 1.0 U/ml, and 59.53 
  8  22.36 pg/  g protein at thrombin 5.0 U/ml ( fig. 1 a). The mean level of GM-CSF from three 
wells was 0.06   8   0.03 pg/    g protein at thrombin 0 U/ml, 0.24   8   0.06 pg/    g protein at 
thrombin 0.5 U/ml, 1.19  8  0.45 pg/  g protein at thrombin 1.0 U/ml, and 2.38  8  0.83 pg/  g 
protein at thrombin 5.0 U/ml (  fig. 1  b). The mean level of G-CSF from three wells was 0.023 
  8   0.006 pg/    g protein at thrombin 0 U/ml, 0.053   8   0.013 pg/    g protein at thrombin 
  Fig. 1.   Effect of thrombin on M-CSF (  a ),  GM-CSF 
(  b ) and G-CSF ( c ) production in PTEC. PTEC were 
incubated with thrombin (0–5.0 U/ml) for 72 h and 
the cell supernatant was quantified by ELISA. 5
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0.5 U/ml, 0.053  8  0.031 pg/  g protein at thrombin 1.0 U/ml, and 0.206  8  0.075 pg/  g pro-
tein at thrombin 5.0 U/ml (  fig. 1  c). Thrombin 5.0 U/ml significantly increased M-CSF (p   !  
0.01) and G-CSF (p   !   0.01). Thrombin 1.0 U/ml and 5.0 U/ml significantly increased GM-
CSF (p  !  0.02 and p  !  0.01, respectively; 1.0 U/ml vs. 5.0 U/ml: p  !  0.02) in a dose-dependent 
manner. 
  The time effect of thrombin was also examined by incubating PTEC with or without 5.0 
U/ml thrombin for 24, 48, and 72 h. Thrombin significantly stimulated the production of 
M-CSF (p   !   0.005,   fig. 2  a), GM-CSF (p   !   0.0005,   fig. 2  b) and G-CSF (p   !   0.05,   fig. 2  c) in a 
time-dependent manner.
    Inhibitory Effect of Argatroban on Thrombin-Induced Production of M-CSF, GM-CSF 
and G-CSF 
  PTEC were incubated with thrombin 5.0 U/ml with or without argatroban 1    mol  for 
72 h. Argatroban significantly inhibited the increased production of M-CSF (p  !   0.01), GM-
CSF (p   !   0.01) and G-CSF (p   !   0.05) by thrombin (  fig. 3  ).
    Thrombin Stimulates mRNA Expressions of M-CSF, GM-CSF and G-CSF 
  PTEC were incubated with thrombin 5 U/ml for 6 h. The mRNA expressions of M-CSF 
(p   !   0.01,   fig. 4  a), GM-CSF (p   !   0.05,   fig. 4  b) and G-CSF (p   !   0.01,   fig. 4  c) were significantly 
increased compared with control.
  Fig. 2.   Time course of the effect of thrombin on M-
CSF (  a  ), GM-CSF (  b  ) and G-CSF (  c  ) production in 
PTEC. PTEC were incubated in the absence of 
thrombin (control) or with 5.0 U/ml thrombin for 
24–72 h and the cell supernatant was quantified by 
ELISA. Results were compared using the repeated-
measures ANOVA. Thrombin stimulated the pro-
duction of M-CSF (p   !   0 . 0 0 5 ) ,  G M - C S F  ( p    !  
0.0005) and G-CSF (p   !   0.05) in a time-dependent 
manner. 6
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  Discussion 
  Thrombin has various biological effects besides blood coagulation and induces various 
inflammatory cytokines including IL-6  [15]  and TNF-    [16]  via the main thrombin receptor 
proteinase activated receptor-1 (PAR-1). The effect of thrombin on tubular cells is not fully 
  Fig. 3.   Effect of argatroban on thrombin-induced 
M-CSF (  a  ), GM-CSF (  b  ) and G-CSF (  c )  production 
in PTEC. PTEC were incubated with argatroban 
(1     M  ) with or without thrombin (5.0 U/ml) for 
72 h and the cell supernatant was quantified by 
ELISA. 
  Fig. 4.  Effect of thrombin on mRNA expression of M-CSF ( a ), GM-CSF ( b ) and G-CSF ( c ) in PTEC. PTEC 
were incubated with thrombin (5.0 U/ml) for 6 h. 7
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understood. It was, however, shown that tubular cells express PAR-1 and its expression was 
strikingly increased in accordance with the severity of chronic allograft nephropathy   [17]  . 
We have also reported that thrombin stimulates fibronectin production in human PTEC via 
TGF-    -dependent mechanism and suggested that thrombin is a pivotal factor in tubuloint-
erstitial fibrosis.
    There is some evidence that kidney cells produce CSFs. Cultured human PTEC express 
GM-CSF when stimulated with heat-inactivated   Escherichia coli   as shown by immunostain-
ing   [18]  . Besides, M-CSF expression by immunostaining in tubular epithelial cells was in-
creased and its expression level correlated with the activity index of lupus nephritis   [2]  . Fur-
thermore, mesangial cells produce GM-CSF as shown by Northern blotting   [3, 19]  . In this 
study, we proved that PTEC were capable of producing M-CSF, GM-CSF and G-CSF when 
stimulated with thrombin. 
    It is not known how tubular CSFs work in the kidney. However, it is well known that the 
infiltration of inflammatory cells, such as macrophages  [20]  or granulocytes, is an important 
feature of tubulointerstitial injury. Importantly, recent evidence suggests that the phenotype 
of the macrophage is of great importance. GM-CSF induces activated macrophages (M1) 
which are involved in inflammation and host defense, and M-CSF promotes alternatively 
activated macrophages (M2) with an anti-inflammatory and tissue repair phenotype   [1]  .
Interestingly, it was suggested that the macrophage phenotype could be altered in the tubu-
lointerstitium in the kidney. Therefore, we speculate that tubular CSFs may be involved in 
tubulointerstitial injury, possibly via the increased amount of infiltrated cells and their in-
flammatory phenotype. Obviously, we need further studies to elucidate the role of local CSFs 
expression in the pathophysiology of the tubulointerstitium in the kidney.
    In conclusion, we demonstrated that thrombin induced the expressions of M-CSF, GM-
CSF and G-CSF in PTEC, which was proved by ELISA for protein expression and by quan-
titative RT-PCR for mRNA expression. Its effect was significantly reduced by the direct 
thrombin inhibitor argatroban, suggesting the specific effect of thrombin. These changes 
may affect the pathogenesis of tubulointerstitial injury in the kidney.
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